Skip to Main Content

Paper Details

Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy.
Nat Immunol
17
2022
IFN-I, IFN-Is, PD1, Type I interferons, anti-tumor, cancer, immune cells, inflammation, peripheral blood cells, physiological cell states, programmed cell death protein 1, tumor, type I interferon
Author NameAffiliation
Diala Abd-RabboPrincess Margaret Cancer Center, University Health Network
Babak NoamaniPrincess Margaret Cancer Center, University Health Network
Trevor J PughPrincess Margaret Cancer Center, University Health Network
Trevor J PughUniversity of Toronto
Trevor J PughOntario Institute for Cancer Research
Trevor J PughPrincess Margaret Cancer Center, University Health Network
Trevor J PughUniversity of Toronto
Trevor J PughOntario Institute for Cancer Research
  • 1 - 8

Datasets

Release 1.2